tiprankstipranks
Trending News
More News >
KuangChi Science Limited (HK:0439)
:0439
Hong Kong Market
Advertisement

KuangChi Science Limited (0439) AI Stock Analysis

Compare
1 Followers

Top Page

HK:0439

KuangChi Science Limited

(0439)

Select Model
Select Model
Select Model
Neutral 42 (OpenAI - 4o)
Rating:42Neutral
Price Target:
HK$1.50
▲(16.28% Upside)
The overall stock score is primarily impacted by significant financial performance challenges, including negative profitability and cash flow issues. Technical analysis indicates a bearish trend, and valuation metrics are unfavorable due to a negative P/E ratio and lack of dividend yield.

KuangChi Science Limited (0439) vs. iShares MSCI Hong Kong ETF (EWH)

KuangChi Science Limited Business Overview & Revenue Model

Company DescriptionKuangChi Science Limited, an investment holding company, engages in the research and development, manufacture, and sale of future technology products in the People's Republic of China, Hong Kong, the Middle East, and internationally. The company provides KC-PH2, a police smart helmet; and KC N901 Smart Helmet for traffic police bayonet, hospitals, airport/rail transit/bus, pedestrian zone, scenic spots and parks, and office buildings. It also offers various software products, including KcGBS, a streaming media server that provides stream forwarding services; KcFace, a face dynamic comparison engine; and License Plate Recognition that support the recognition of various types of motor vehicle license plates. Further, the company provides administrative services and holds properties. The company was formerly known as Climax International Company Limited and changed its name to KuangChi Science Limited in July 2014. KuangChi Science Limited was incorporated in 1992 and is headquartered in Causeway Bay, Hong Kong. KuangChi Science Limited is a subsidiary of New Horizon Wireless Technology Limited.
How the Company Makes MoneyKuangChi Science Limited generates revenue through multiple streams, primarily by providing high-tech products and solutions in the fields of aerospace and artificial intelligence. Its revenue model includes sales of proprietary technologies and systems to government entities and private enterprises, as well as offering consultancy services for technology integration in smart city projects. Additionally, the company may engage in strategic partnerships with key industry players, which enhance its market reach and can lead to joint ventures or co-development agreements that further generate income. Research grants and funding from governmental and international organizations for innovative projects also contribute to its financial growth.

KuangChi Science Limited Financial Statement Overview

Summary
KuangChi Science Limited faces significant profitability issues as evidenced by negative margins and declining revenue. The balance sheet is sound with low leverage, but persistent losses are eroding equity. Cash flow challenges highlight potential liquidity risks and operational inefficiencies. The company needs strategic adjustments to improve revenue growth and operational efficiency.
Income Statement
45
Neutral
The company's income statement shows significant challenges with profitability. Both the gross profit margin and net profit margin are negative, indicating the company is not covering its expenses with revenues. Revenue has declined from the previous year, and EBIT and EBITDA margins are also negative, signaling operational inefficiencies.
Balance Sheet
70
Positive
The balance sheet reflects a strong equity position with a low debt-to-equity ratio, indicating financial stability. The equity ratio is high, suggesting the company relies more on equity than debt to finance its assets. However, the return on equity is negative due to consistent net losses.
Cash Flow
30
Negative
Cash flow analysis reveals concerns with cash generation, as both operating and free cash flows have been negative or zero, reflecting challenges in generating cash from operations and covering capital expenditures.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue77.14M75.51M83.14M52.52M113.97M99.48M
Gross Profit22.11M20.74M14.68M10.83M41.73M38.58M
EBITDA-65.72M-74.79M-4.51M-61.82M-29.28M-25.02M
Net Income-40.38M-47.43M-7.29M-67.91M-40.61M-78.33M
Balance Sheet
Total Assets2.95B3.20B1.83B1.98B2.77B2.84B
Cash, Cash Equivalents and Short-Term Investments84.52M152.56M263.55M164.96M318.68M150.76M
Total Debt110.93M90.49M115.50M141.74M178.95M497.97M
Total Liabilities454.60M474.25M334.40M362.69M545.67M904.76M
Stockholders Equity2.49B2.73B1.49B1.62B2.22B1.94B
Cash Flow
Free Cash Flow-86.81M-94.51M-52.68M-92.82M82.82M-10.62M
Operating Cash Flow-71.22M-80.87M-43.59M-77.91M105.22M3.40M
Investing Cash Flow167.01M162.66M43.10M-104.25M369.21M-64.92M
Financing Cash Flow4.12M-21.65M-22.38M-23.79M-325.97M-42.38M

KuangChi Science Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1.29
Price Trends
50DMA
1.61
Negative
100DMA
1.43
Negative
200DMA
1.56
Negative
Market Momentum
MACD
-0.08
Positive
RSI
29.36
Positive
STOCH
19.09
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0439, the sentiment is Negative. The current price of 1.29 is below the 20-day moving average (MA) of 1.49, below the 50-day MA of 1.61, and below the 200-day MA of 1.56, indicating a bearish trend. The MACD of -0.08 indicates Positive momentum. The RSI at 29.36 is Positive, neither overbought nor oversold. The STOCH value of 19.09 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0439.

KuangChi Science Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
HK$876.00M1.7412.24%13.37%15.55%
HK$950.47M3.658.32%4.18%8.09%30.76%
$10.79B15.437.44%2.01%2.89%-14.66%
HK$1.25B10.983.91%3.73%20.53%28.42%
HK$718.56M-2.15-89.45%12.16%-16700.00%
HK$646.36M-2.64-98.45%-32.75%38.59%
HK$905.07M-1.99%-5.59%-1071.43%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:0439
KuangChi Science Limited
1.29
-0.48
-27.12%
HK:0232
Continental Aerospace Technologies Holding Ltd.
0.13
<0.01
3.08%
HK:1463
C-Link Squared Limited
0.25
-0.15
-37.50%
HK:1725
Hong Kong Aerospace Technology Group Limited
0.96
-0.49
-33.79%
HK:1756
China Vocational Education Holdings Limited
0.71
0.10
16.39%
HK:2377
China Boqi Environmental (Holding) Co., Ltd.
1.12
0.27
31.76%

KuangChi Science Limited Corporate Events

KuangChi Science Limited Proposes Name Change to Genesis Scale Holdings
Oct 15, 2025

KuangChi Science Limited has proposed to change its English name to Genesis Scale Holdings Limited and adopt a new Chinese name. This change aims to provide a fresh corporate image that supports future business development. The name change is subject to shareholder approval and regulatory consent in Bermuda. The change will not affect shareholder rights, and existing share certificates will remain valid.

The most recent analyst rating on (HK:0439) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on KuangChi Science Limited stock, see the HK:0439 Stock Forecast page.

KuangChi Science Limited Proposes New Share Option Scheme
Oct 15, 2025

KuangChi Science Limited has announced the expiration of its 2012 Share Option Scheme, which was adopted on July 31, 2012, and expired on July 30, 2022. In response, the company proposes to adopt a New Share Option Scheme to provide incentives for participants contributing to the company’s growth. This proposal is subject to shareholder approval and the necessary permissions from the Stock Exchange. The new scheme aims to continue motivating and rewarding participants, aligning with the company’s strategic goals.

The most recent analyst rating on (HK:0439) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on KuangChi Science Limited stock, see the HK:0439 Stock Forecast page.

KuangChi Science Limited Announces Executive Leadership Changes
Sep 10, 2025

KuangChi Science Limited has announced a change in its executive directors, with Dr. Liu Ruopeng, Dr. Luan Lin, and Dr. Ji Chunlin resigning to focus on other business commitments. The company has appointed Dr. Liu Weiwen, the current CEO, and Mr. Lin Ge as new executive directors, effective from September 10, 2025. This leadership change is part of the company’s ongoing management restructuring, which may impact its strategic direction and operational focus.

KuangChi Science Limited Announces Board Composition and Committee Membership
Sep 10, 2025

KuangChi Science Limited has announced the composition of its board of directors, which includes executive, non-executive, and independent non-executive directors. The company has also detailed the membership of its board committees, which are the Audit Committee, Nomination Committee, and Remuneration Committee. This announcement provides clarity on the leadership structure and governance of KuangChi Science Limited, potentially impacting its strategic direction and stakeholder engagement.

KuangChi Science Limited Reports Interim Results with Revenue Growth
Aug 29, 2025

KuangChi Science Limited reported its unaudited interim results for the six months ending June 30, 2025, showing a revenue increase to HK$33,656,000 from HK$32,028,000 in the same period of 2024. Despite a rise in gross profit, the company faced an operating loss of HK$4,504,000, although it achieved a net profit of HK$1,821,000, marking a significant turnaround from a loss in the previous year.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 25, 2025